05 August 2022 | NewsRegister now | NCIRS webinar - Emerging vaccine preventable diseases and vaccination for travelRead the full article
The Australian Technical Advisory Group on Immunisation (ATAGI) has provided an updated statement on the administration of influenza vaccines in 2021.
During the COVID-19 pandemic there has been reduced circulation of influenza virus. However, as Australia opens its borders to international travellers, influenza virus may start to re-emerge and circulate widely in the country. There were also lower levels of influenza vaccine coverage in 2021 compared to previous years for a number of age groups.
Hence, vaccination with the 2021 influenza vaccine is recommended to prevent influenza and its complications for anyone ≥6 months of age who has not had an influenza vaccine this year. Some of the available 2021 influenza vaccines can be used until February 2022.
Vaccination is strongly recommended for vulnerable groups, including adults aged ≥65 years, children 6 months to <5 years of age, pregnant women, people with an increased risk of complications from influenza including those with underlying medical conditions, and Aboriginal and Torres Strait Islander peoples ≥6 months of age.
People planning international travel are also recommended to receive the 2021 influenza vaccine before travel.
Read the full statement here
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Copyright © 2022 NCIRS. All rights reserved
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Stay updated with the latest from NCIRS